Gliomatosis cerebri: Post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide

Citation
C. Mawrin et al., Gliomatosis cerebri: Post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide, J NEURO-ONC, 55(1), 2001, pp. 11-17
Citations number
29
Categorie Soggetti
Oncology
Journal title
JOURNAL OF NEURO-ONCOLOGY
ISSN journal
0167594X → ACNP
Volume
55
Issue
1
Year of publication
2001
Pages
11 - 17
Database
ISI
SICI code
0167-594X(200110)55:1<11:GCPMAI>2.0.ZU;2-S
Abstract
Gliomatosis cerebri (GC) is a rare tumor of the central nervous system (CNS ) characterized by widespread diffuse infiltration of the brain and spinal cord by neoplastic glial cells. We report the case of a 17-year-old boy wit h a bioptically diagnosed fibrillary astrocytoma. The administration of tha lidomide, which was suggested to be beneficial in the treatment of human ca ncers, had no substantial clinical effect on our patient. Autopsy studies r evealed a diffuse infiltration of the frontal and temporal lobes of the rig ht hemisphere, brainstem, and the leptomeninges covering the whole spinal c ord by an astrocytic tumor, which showed features both of low-grade astrocy toma and glioblastoma multiforme. No mutations in the p53 and PTEN tumor su ppressor genes were found; immunoreactivities for p53, PTEN, and EGFR could not be detected.